- Home
- MXF vs GALT Comparison
MXF vs GALT Comparison
Compare MXF & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MXF | GALT |
|---|---|---|
| Founded | 1981 | 2000 |
| Country | Mexico | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 289.0M | 232.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MXF | GALT |
|---|---|---|
| Price | $20.30 | $6.29 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 27.4K | ★ 465.8K |
| Earning Date | 01-01-0001 | 11-14-2025 |
| Dividend Yield | ★ 4.70% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.77 | $0.73 |
| 52 Week High | $19.49 | $6.66 |
Technical Indicators
Market Signals| Indicator | MXF | GALT |
|---|---|---|
| Relative Strength Index (RSI) | 66.86 | 58.86 |
| Support Level | $19.65 | $5.10 |
| Resistance Level | $20.30 | $6.40 |
| Average True Range (ATR) | 0.28 | 0.53 |
| MACD | 0.08 | 0.02 |
| Stochastic Oscillator | 85.68 | 76.28 |
Price Performance
Historical ComparisonAbout MXF Mexico Fund Inc. (The)
Mexico Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation. The fund seeks to achieve its objective through investment in securities, primary in equity, listed on the Mexican Stock Exchange. The company's portfolio of investments consists of investments in different sectors such as auto parts, airports, building materials, chemical products, consumer products, energy, food, and other sectors. The fund provides a vehicle to investors who wish to invest in Mexican companies through a managed non-diversified portfolio as part of their overall investment program.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.